3 unknown, 1 recruiting. 4 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 3, Recruiting 1 |
| Phase 1 | 3 | Unknown 2, Recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow hUC-MSCs: new trials by email Literature Review of hUC-MSCs trials Research Report on hUC-MSCs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ⅰ/Ⅱa Trial Evaluating Intravenous hUC-MSCs Injection for Safety, Tolerability and Efficacy in Patients With POI hUC-MSCs Injection (Phase I), hUC-MSCs Injection (Phase IIa), Placebo - Premature Ovarian Insufficiency | Phase 1 / Phase 2 | Recruiting | Shenzhen Wingor Biotechnology Co., Ltd. | 59 | 2026-08-03 | 2026-08-20 |
| HUC-MSC for Treatment of High-risk HPV Infection hUC-MSCs, Saline+albumin - Human Papillomavirus Viruses, Mesenchymal Stem Cells | Phase 1 / Phase 2 | Unknown | Shanghai East Hospital | 60 | 2024-03-01 | 2024-09-24 |
| Treatment With Human Umbilical Cord Mesenchymal Stem Cells for Refractory Diabetic Peripheral Neuropathy HUC-MSCs, Lipoic Acid - Diabetic Peripheral Neuropathy Type 2 | Phase 1 / Phase 2 | Unknown | Wuhan Central Hospital | 42 | 2022-05-19 | 2022-08-19 |
| Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions huc-MSCs, Placebo - Ischemic-type Biliary Lesions | Phase 2 / Phase 3 | Unknown | Yang Yang | 66 | 2014-07-01 | 2014-08-22 |
Diabetes Mellitus, Type 2 (1) · Primary Ovarian Insufficiency (1)
Shanghai East Hospital (1) · Shenzhen Wingor Biotechnology Co., Ltd. (1) · Wuhan Central Hospital (1) · Yang Yang (1)
China (4)
Fang Li, M.D,.PH.D. (1) · Yang Yang, MD (1)